VALUE OF CT – GUIDED CORE NEEDLE BIOPSY IN DIAGNOSIS RETROPERITONEAL MASSES AT K HOSPITAL

Thúy Hằng Vũ 1,
1 k hospital

Main Article Content

Abstract

Objectives: This study aims to evaluate the value of CT- guided core needle biopsy in diagnosis retroperitoneal masses at K hospital. Marterial and methods: 37 patients were diagnosed with retroperitoneal mass based on clinical, ultrasound and CT - scanner, were taken CT -guided core needle biopsy preoperative by 16 - 18 G - semi - automatic biopsy at Department of diagnostic imaging of K hospital. All patients had result of pathological diagnosis post – biopsy and post – operative from October 2021 to October 2022. It is descriptive cross-sectional, prospective study. Results: All of patient’s specimens has been pathological diagnosed. In there, 29 cases got malignant masses, and 8 cases got benign mases. 3 cases got mild complication as a small hematoma around the lesion after biopsy processing, 1 case got pain requiring analgesics. There were not any cases got serious bleeding complication, infection and not any cases had tumor transplant complications on the biopsy path with a follow-up period of 3 months. Sensitivity, specificity, positive diagnostic value, negative diagnostic value, and accuracy of  CT – guided core needle biopsy in diagnosis retroperitoneal masses were 93.1%, 100%, 100%, 80%, 94,6%, respectively. Conclusions: CT-guided core needle biopsy for retroperitoneal masses is safe and high valuable method in diagnosing the retroperitoneal tumor’s pathology.

Article Details

References

1. Nishino M, Hayakawa K, Minami M, Yamamoto A, Ueda H, Takasu K. Primary Retroperitoneal Neoplasms: CT and MR Imaging Findings with Anatomic and Pathologic Diagnostic Clues. RadioGraphics. 2003;23(1):45-57. doi:10.1148/rg.231025037
2. Ahrar K, Gupta S, eds. Percutaneous Image-Guided Biopsy. Springer New York; 2014. doi:10.1007/978-1-4614-8217-8
3. Veltri A, Bargellini I, Giorgi L, Almeida PAMS, Akhan O. CIRSE Guidelines on Percutaneous Needle Biopsy (PNB). Cardiovasc Intervent Radiol. 2017;40(10):1501-1513. doi:10.1007/s00270-017-1658-5
4. An JY, Heo JS, Noh JH, et al. Primary malignant retroperitoneal tumors: Analysis of a single institutional experience. Eur J Surg Oncol EJSO. 2007;33(3):376-382. doi:10.1016/ j.ejso.2006.10.019
5. Tomozawa Y, Inaba Y, Yamaura H, et al. Clinical Value of CT-Guided Needle Biopsy for Retroperitoneal Lesions. Korean J Radiol. 2011;12(3):351. doi:10.3348/kjr.2011.12.3.351
6. El-Badrawy A, Tawfik A, Abdelfattah S, et al. Contrast-Enhanced CT-Guided Core Biopsy of Retroperitoneal Masses. Open J Radiol. 2014;04 (01):130-135. doi:10.4236/ojrad.2014.41017
7. Wilkinson MJ, Martin JL, Khan AA, Hayes AJ, Thomas JM, Strauss DC. Percutaneous Core Needle Biopsy in Retroperitoneal Sarcomas Does Not Influence Local Recurrence or Overall Survival. Ann Surg Oncol. 2015;22(3):853-858. doi:10.1245/s10434-014-4059-x
8. Berger-Richardson D, Burtenshaw SM, Ibrahim AM, et al. Early and Late Complications of Percutaneous Core Needle Biopsy of Retroperitoneal Tumors at Two Tertiary Sarcoma Centers. Ann Surg Oncol. 2019;26(13):4692-4698. doi:10.1245/s10434-019-07656-6